Q32 Bio Inc. · SWB:DB0
Q32 Bio Inc. shareholders
As of Sep 30, 2026, 103 institutions reported holding Q32 Bio Inc. Largest: Orbimed Advisors LLC, Atlas Venture Life Science Advisors, LLC and Boxer Capital Management, LLC. New holders, exits, insiders and big stakes, each with its filing.
Shareholders
Institutions
| Holder | Shares | Value | As of |
|---|---|---|---|
| Orbimed Advisors LLC | 4.13M | US$34.1M | Sep 30, 2026 |
| Atlas Venture Life Science Advisors, LLC | 2.72M | US$22.5M | Sep 30, 2026 |
| Boxer Capital Management, LLC | 2.58M | US$21.3M | Sep 30, 2026 |
| Bvf Inc | 2.35M | US$19.4M | Sep 30, 2026 |
| Ra Capital Management, L.P. | 2.33M | US$19.3M | Sep 30, 2026 |
| Bank of America | 2.2M | US$18.2M | Sep 30, 2026 |
| T. Rowe Price | 1.5M | US$12.4M | Sep 30, 2026 |
| Vanguard | 1.15M | US$9.48M | Sep 30, 2026 |
| Opaleye Management Inc. | 1.12M | US$9.26M | Sep 30, 2026 |
| JPMorgan | 1.06M | US$10.1M | Sep 30, 2026 |
| American Century | 653K | US$5.4M | Sep 30, 2026 |
| Citadel | 623K | US$5.16M | Sep 30, 2026 |
| Baker Bros. Advisors LP | 548K | US$4.53M | Sep 30, 2026 |
| Sio Capital Management, LLC | 529K | US$4.38M | Sep 30, 2026 |
| Ameriprise | 500K | US$4.14M | Sep 30, 2026 |
| Sphera Funds Management LTD. | 449K | US$3.71M | Sep 30, 2026 |
| Qube Research & Technologies Ltd | 381K | US$3.15M | Sep 30, 2026 |
| Marshall Wace, LLP | 369K | US$3.05M | Sep 30, 2026 |
| Point72 Asset Management, L.P. | 345K | US$2.86M | Sep 30, 2026 |
| Ikarian Capital, LLC | 345K | US$2.85M | Sep 30, 2026 |
| BlackRock | 340K | US$2.81M | Sep 30, 2026 |
| abrdn | 303K | US$2.5M | Sep 30, 2026 |
| Goldman Sachs | 289K | US$2.39M | Sep 30, 2026 |
| Cantor Fitzgerald, L. P. | 258K | US$2.14M | Sep 30, 2026 |
| Millennium | 248K | US$2.05M | Sep 30, 2026 |
| Sanofi | 244K | US$2.02M | Sep 30, 2026 |
| Geode Capital | 241K | US$1.99M | Sep 30, 2026 |
| Acorn Capital Advisors, LLC | 216K | US$1.79M | Sep 30, 2026 |
| Squarepoint Ops LLC | 192K | US$1.59M | Sep 30, 2026 |
| TD | 190K | US$1.81M | Sep 30, 2026 |
| Walleye Capital LLC | 182K | US$1.51M | Sep 30, 2026 |
| UBS | 164K | US$1.36M | Sep 30, 2026 |
| Jane Street | 161K | US$1.33M | Sep 30, 2026 |
| Wellington | 137K | US$1.14M | Sep 30, 2026 |
| Woodline Partners LP | 130K | US$1.07M | Sep 30, 2026 |
| Acadian Asset Management LLC | 121K | US$998K | Sep 30, 2026 |
| Velan Capital Investment Management LP | 120K | US$992K | Sep 30, 2026 |
| Caption Management, LLC | 112K | US$927K | Sep 30, 2026 |
| Dimensional | 110K | US$912K | Sep 30, 2026 |
| Manufacturers Life Insurance Company, The | 108K | US$892K | Sep 30, 2026 |
| Boothbay Fund Management, LLC | 106K | US$876K | Sep 30, 2026 |
| Ghisallo Capital Management LLC | 100K | US$827K | Sep 30, 2026 |
| Balyasny Asset Management L.P. | 99,755 | US$825K | Sep 30, 2026 |
| DAFNA Capital Management LLC | 98,500 | US$815K | Sep 30, 2026 |
| Nutshell Asset Management Ltd | 98,299 | US$813K | Sep 30, 2026 |
| First Trust | 89,134 | US$737K | Sep 30, 2026 |
| State Street | 88,114 | US$729K | Sep 30, 2026 |
| Arrowstreet Capital, Limited Partnership | 75,515 | US$625K | Sep 30, 2026 |
| Renaissance Technologies | 69,800 | US$577K | Sep 30, 2026 |
| Susquehanna | 66,305 | US$548K | Sep 30, 2026 |
This page holds 50 of 103 holders.
Funds
Big stakes
| Stake | Stake | Shares | Date | Filing |
|---|---|---|---|---|
| Orbimed Advisors LLC | 13.90% | 4.13M | Jul 16, 2026 | Schedule 13D |
| BVF PARTNERS L P/IL | 9.99% | 3.04M | Sep 30, 2026 | Schedule 13G |
| Ra Capital Management, L.P. | 9.90% | 3.05M | Sep 30, 2026 | Schedule 13G |
| Boxer Capital Management, LLC | 7.90% | 2.36M | Sep 30, 2026 | Schedule 13G |
| Bank of America Corp | 7.40% | 2.21M | Sep 30, 2026 | Schedule 13G |
| Frazier Life Sciences Public Fund, L.P. | 5.90% | 1.76M | Oct 2, 2026 | Schedule 13G |
| T. Rowe Price Associates Inc | 5.00% | 1.5M | Sep 30, 2026 | Schedule 13G |
| Atlas Venture Fund X, L.P. | 3.60% | 864K | May 26, 2026 | Schedule 13D |